Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC
Clinical trial NCT05189730 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05189730
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2025-01-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.